Browse Technologies

Displaying 61 - 70 of 184


Wireless soft robots for in vivo mucus property measurement

The material properties of mucus, such as viscosity and pH, provide information about the well-being of various organ systems. To improve accessibility to mucus sites from throughout the body and increase the validity of measurements, Vanderbilt researchers have developed a wireless millimeter-scale soft robot for direct and accurate mucus sensing throughout the body.


Licensing Contact

Philip Swaney

615.322.1067
Medical Devices

Silicone Airway Stent with Wirelessly Actuated Cilia for Mucus Removal

Various widespread diseases associated with airway constriction can be combatted using airway stents. However, such stents are either prone to clogging themselves or tend to invade neighboring tissue. Vanderbilt engineers have developed a technology that avoids both of these pitfalls by combining the use of tissue-friendly silicone with active cilia for mucus clearing.


Licensing Contact

Philip Swaney

615.322.1067
Medical Devices

Quantitative rapid diagnostic platform using porous silicon on paper

This technology combines the sensitivity of porous silicon with the speed of lateral flowassays to create a point-of-care diagnostic platform capable of rapidly and accuratelymeasuring biomarkers.


Licensing Contact

Cameron Sargent

615.322.5907
Diagnostics
Infectious Disease

Zero-waste, pre-portioned sunscreen capsule

Vanderbilt has developed an innovative sunscreen delivery system that promotes the proper usage of sunscreen while also using zero-waste packaging.


Licensing Contact

Carlos Detres Roman

615.343.2430

Anti-inflammatory microparticles for sustained ocular drug delivery

Vanderbilt researchers have developed an injectable drug delivery vehicle using microparticles (MPs) that not only provide sustained cargo delivery over extended time but also play a therapeutic role themselves in reducing inflammation. This drug delivery platform can be used in treating ocular diseases such as glaucoma and traumatic optic neuropathy, as well as other inflammatory diseases throughout the body like peripheral arterial disease and osteoarthritis.


Licensing Contact

Taylor Jordan

615.936.7505

ML-powered software for planning sleep apnea surgery

High-resolution pharyngeal manometry (HRM) provides an inexpensive and objective method for analyzing the pharynx during natural sleep and can be utilized to select candidates for certain surgical procedures for obstructive sleep apnea (OSA).


Licensing Contact

Chris Harris

615.343.4433

Head Motion Correction with Soft Pressure Pad for MRI Scans

Vanderbilt University researchers have developed a novel soft pressure sensing pad to track head motion during MRI to improve diagnostic image quality and reduce erroneous artifacts.


Licensing Contact

Chris Harris

615.343.4433

Surgical Guide for Intraoral Vertical Ramus Osteotomy

Vanderbilt researchers have developed a novel surgical guide for intraoral vertical ramus osteotomy (IVRO) that helps to preserve the proximal segment medial pterygoid attachment and avoid injury to the inferior alveolar neurovascular bundle during the procedure.


Licensing Contact

Philip Swaney

615.322.1067
Medical Devices

Targeting PD-1H to treat Acute Myeloid Leukemia (AML)

Despite the success of immune checkpoint inhibitors (ICI) like anti-PD-1 in treating other cancers, these therapeutics have not been demonstrated to effectively treat acute myeloid leukemia (AML). Vanderbilt researchers have identified PD-1H as a potential target for treating AML, opening the door for effective therapy using an ICI molecule.


Licensing Contact

Cameron Sargent

615.322.5907

Inventors

Tae Kon Kim
Therapeutics
Oncology

Targeted photodynamic therapy for S. aureus infections

Vanderbilt researchers have developed a combination photodynamic therapy (PDT) for targeting MRSA infections in skin that is not only effective but also HIGHLY SPECIFIC and LESS SUSCEPTIBLE TO RESISTANCE, adding a much needed therapy to our quickly depleting arsenal against this pathogen.


Licensing Contact

Cameron Sargent

615.322.5907